Table 3.
ΔSlope* | 95% CI |
p | ||
---|---|---|---|---|
LL | UL | |||
Sex modification | ||||
Female versus Male* | ||||
Contrasts | ||||
FCRS | ||||
Primary Outcomes | ||||
Global Cognition | 0.009 | 0.006 | 0.013 | 0.000 |
SIS≤4 | −0.002 | −0.004 | 0.000 | 0.011 |
Secondary Outcomes | ||||
SEVLT-Recall | 0.006 | 0.002 | 0.009 | 0.002 |
SEVLT-Sum | 0.007 | 0.004 | 0.011 | 0.000 |
WF | 0.005 | 0.002 | 0.009 | 0.003 |
DSS | 0.009 | 0.006 | 0.012 | 0.000 |
GVRS | ||||
Primary Outcomes | ||||
Global Cognition | 0.023 | 0.015 | 0.031 | 0.000 |
SIS≤4 | −0.005 | −0.008 | −0.001 | 0.011 |
Secondary Outcomes | ||||
SEVLT-Recall | 0.017 | 0.008 | 0.025 | 0.000 |
SEVLT-Sum | 0.015 | 0.007 | 0.023 | 0.000 |
WF | 0.012 | 0.004 | 0.020 | 0.005 |
DSS | 0.023 | 0.015 | 0.031 | 0.000 |
Age modification | ||||
Age 45–64 versus 65+* Contrasts | ||||
FCRS | ||||
Primary Outcomes | ||||
Global Cognition | 0.006 | 0.002 | 0.010 | 0.001 |
SIS≤4 | 0.000 | −0.002 | 0.002 | 0.738 |
Secondary Outcomes | ||||
SEVLT-Recall | 0.003 | −0.001 | 0.007 | 0.109 |
SEVLT-Sum | 0.003 | 0.000 | 0.007 | 0.063 |
WF | 0.000 | −0.005 | 0.004 | 0.889 |
DSS | 0.009 | 0.006 | 0.013 | <0.001 |
GVRS | ||||
Primary Outcomes | ||||
Global Cognition | 0.021 | 0.011 | 0.031 | <0.001 |
SIS≤4 | −0.004 | −0.009 | 0.001 | 0.091 |
Secondary Outcomes | ||||
SEVLT-Recall | 0.016 | 0.007 | 0.026 | 0.001 |
SEVLT-Sum | 0.013 | 0.002 | 0.023 | 0.015 |
WF | 0.002 | −0.009 | 0.014 | 0.681 |
DSS | 0.028 | 0.019 | 0.036 | <0.001 |
FCRS, Framingham Cardiovascular Risk Score; GVRS, Global Vascular Risk Score; Global Cognition, Composite factor score; SIS, Six-item Screener; SEVLT, Spanish English verbal learning test; WF, word fluency; DSS, digit symbol substitution; CI, confidence intervals (LL lower limit; and UL upper limit).; Models are adjusted for education, Hispanic/Latino background, CESD-10, and study site.;
Calculated group differences in slopes (Slope Males – Slope Females; Slope age 65+– Slope age 45–64 years) per 1% increase in cardiovascular risk score.